Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Issue 447


Test Your Knowledge Issue 447

A 32-year-old woman who has had type 1 diabetes for 20 years is evaluated because of fatigue, bloating, and intermittent diarrhea. She has lost 2.3 kg (5 lb) over the past 6 months.


Change at the FDA

David Kliff, Publisher, Diabetic Investor, has been looking at the President-elect’s recent appointments and keeps wondering who will be the new head the Food and Drug Administration. Whoever it is will have an interesting road ahead of...


Why How Much Insulin You Have “on Board” during Exercise Matters

More and more of our patients using insulin are exercising and participating in sports. They often lower their basal rates or decrease their mealtime dose to try and compensate. This can lead to hyperglycemia or hypoglycemia after exercising. Why...


Fibrate Drug Does Not Cut Heart Risks In Diabetics

Long-term treatment with fenofibrate, a type of fibrate drug often used to lower cholesterol, does not reduce coronary plaques or signs of "atherosclerosis" in patients with type 2 diabetes, according to a published report.


Type 2 Diabetes An Addiction?

Sugar as addictive as cocaine, heroin, studies suggest. Start your day with protein.


Diabetes Drugs 'Double Bone Risk'

Long-term use of a class of drugs for type 2 diabetes doubles a woman's risk of breaking a bone, research suggests.


Effect of Cranberry Extracts On Lipid Profiles Of Type 2 Patients

Cranberry supplements are effective in reducing atherosclerotic cholesterol profiles.


Body Clock Linked to Diabetes And High Blood Sugar

Diabetes and high levels of blood sugar may be linked to abnormalities in a person's body clock and sleep patterns, according to a genome-wide association study


Sitagliptin Reduces Blood Glucose In Elderly Type 2’s

Elderly patients assigned to once-daily sitagliptin experienced significant reductions in blood glucose without the risk for hypoglycemia in a new study.


Fructose Metabolism - What You Don’t Know!

A new University of Illinois study suggests that we may pay a price for ingesting too much fructose. According to lead author Manabu Nakamura, dietary fructose affects a wide range of genes in the liver that had not previously been identified.


New Genes Present Drug Targets For Managing Cholesterol And Glucose Levels

Scientists have identified 12 new genes that link gallstones and blood cholesterol levels, others link melatonin and sleep patterns to small increases in glucose levels and larger jumps in the risk of diabetes.


Thiamine Reverses Early Diabetic Kidney Disease in 35% of Type 2 Patients

Researchers have discovered high doses of thiamine - vitamin B1 - can reverse the onset of early diabetic kidney disease.


Fast Heart Rate Warns of Obesity, Diabetes

A too-fast heartbeat in early adulthood is a warning sign for increased risk of cardiovascular problems decades later on, a Japanese study suggests.


Weight Loss Drug Qnexa Reduces Hemoglobin A1c By 1.6% & Wt By 9%

Significant weight loss achieved and maintained by diabetic subjects.


Low-Glycemic Diet Better Than High-Fiber Diet for Type 2’s

Persons with type 2 diabetes who had a diet high in low-glycemic foods such as nuts, beans and lentils had greater improvement in glycemic control and risk factors for coronary heart disease than persons on a diet with an emphasis on high-cereal...


Low-Dose Terbutaline Can Prevent Nocturnal Hypoglycemia in Type 1’s

A 2.5-mg dose of terbutaline at bedtime appears to prevent hypoglycemia during the night in patients with aggressively treated type 1 diabetes, without causing hyperglycemia the following morning, results of a pilot study indicate.


SGLT2 Inhibitors a Promising New Therapy for Type II Diabetes

A new drug class is poised to make a splash in the diabetes market, according to a new report, "Diabetes Market Forecast to 2013"


Benefit of Prior Intensive Diabetes Therapy on Retinopathy Risk Wanes Over Time

The persistent difference in retinopathy complications between former intensive and conventional therapy for type 1 diabetes continues for years, but begins to decline within a decade, according to new data from the Epidemiology of Diabetes...


 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Do your type 2 patients not on insulin count their carbs and report back to you?

Navigate Diabetes In Control


Advertisement


Search Articles On Diabetes In Control